Selective CD4+ T cell deletion after specific activation in HIV- infected individuals; Protection by anti-CD28 monoclonal antibodies

Clinical and Experimental Immunology

Volumn 105, Issue 1, 1996, Pages 31-38

  Cottrez, F ^a   Capron, A ^a   Groux, H ^a,b  

^a INSTITUT PASTEUR DE LILLE   (France)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

anti CD28 MoAb; apoptosis; CD4+ T cells; HIV; V repertoire

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; MESSENGER RNA; MONOCLONAL ANTIBODY; PHYTOHEMAGGLUTININ; POKEWEED MITOGEN; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOFLUOROMETRY; GENE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROVIRUS; T LYMPHOCYTE;

EID: 0030015783     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-716.x     Document Type: Article

References (39)

1. Shearer G, Payne MSM, Joseph LJ, Biddison WE. Functional T lymphocte immune deficiency in a population of homosexual men who do not exhibit symptoms of acquired immune deficiency syndrome. J Clin Invest 1984; 74:496-506.
2. Lane HC Depper JM, Greene WC, Whalen G, Waldmann TA, Fauci AS. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N Engl J Med 1985; 313:79-84.
3. + cell numbers and clinical staging. J Clin Invest 1989; 84:1892-9.
4. + T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 1992; 175:331-40.
5. Hofmann B, Jakobsen KD, Odum N et al. HIV-induced immunodeficiency. Relatively preserved phytohemagglutinin as opposed to decreased pokeweed mitogen responses may be due to possibly preserved responses via CD2/phytohemagglutinin pathway. J Immunol 1989; 142:1874-80.
6. + T helper cell depletion occurs. J Clin Invest 1988; 82:1908-14.
7. Gougeon ML, Garcia S, Heeney J et al. Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res Hum Retroviruses 1993; 9:553-63.
8. Estaquier J, Idziorek T, de Bels F et al. Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc Natl Acad Sci USA 1994; 91:9431-5.
9. Teeuwsen VJ, Siebelink KH, de Wolf F, Goudsmit J, Uytde Haag FG, Osterhaus AD. Impairment of in vitro immune responses occurs within 3 months after HIV-1 seroconversion. Aids 1990; 4:77-81.
10. Surh CD, Sprent J. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 1994; 372:100-3.
11. Finkel TH, Tudor-Williams G, Banda NK. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV-and SIV-infected lymph nodes. Nature Medicine 1995; 1:129.
12. Muro-Cacho CA, Pantaleo G, Fauci AS. Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J Immunol 1995; 154:5555-66.
13. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RP, Miedema F. Programmed death of T cells in HIV-1 infection. Science 1992; 257:217-9.
14. Oyaizu N, McCloskey TW, Coronesi M, Chirmule N, Kalyanaraman VS, Pahwa S. Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood 1993; 82:3392-400.
15. Meyaard L, Otto SA, Keet IP, Roos MT, Miedema F. Programmed death of T cells in human immunodeficiency virus infection. No correlation with progression to disease. J Clin Invest 1994; 93:982-8.
16. Razvi ES, Welsh RM. Programmed cell death of T lymphocytes during acute viral infection: a mechanism for virus-induced immune deficiency. J Virol 1993; 67:5754-65.
17. Moss DJ, Bishop CJ, Burrows SR, Ryan JM. T lymphocytes in infectious mononucleosis. I. T cell death in vitro. Clin Exp Immunol 1985; 60:61-69.
18. Uehara T, Miyawaki T, Ohta K, Tamaru Y, Yokoi T, Nakamura S, Taniguchi N. Apoptotic cell death of primed CD45RO: T lymphocytes in Epstein-Barr virus-induced infectious mononucleosis. Blood 1992; 80:452-8.
19. Clerici M, Lucey DR, Berzofsky JA et al. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 1993; 262:1721-4.
20. Groux H, Monte D, Plouvier B, Capron A, Ameisen JC. CD3-mediated apoptosis of human medullary thymocytes and activated peripheral T cells: respective roles of interleukin-1, interleukin-2, interferon-gamma and accessory cells. Eur J Immunol 1993; 23: 1623-9.
21. Wyllie AH, Morris RG. Hormone-induced cell death. Purification and properties of thymocytes undergoing apoptosis after glucocorticoid treatment. Am J Pathol 1982; 109:78-87.
22. Cottrez F, Auriault C, Capron A, Groux H. Analysis of the V beta specificity of superantigen activation with a rapid and sensitive method using RT PCR and an automatic DNA analyser. J Immunol Methods 1994; 172:85-94.
23. Choi YW, Kotzin B, Herron L, Callahan J, Marrack P, Kappler J. Interaction of Staphylococcus aureus toxin 'superantigens' with human T cells. Proc Natl Acad Sci USA 1989; 86:8941-5.
24. Boyer V, Smith LR, Ferre F, Pezzoli P, Trauger RJ, Jensen FC, Carlo DJ. T cell receptor V beta repertoire in HIV-infected individuals: lack of evidence for selective V beta deletion. Clin Exp Immunol 1993; 92:437-41.
25. Meyaard L, Kuiper H, Otto SA, Wolthers KC, van Lier RA, Miedema F. Evidence for intact costimulation via anti-CD28 and CD27 molecules in hyporesponsive T cells from human immunodeficiency virus-infected individuals. Eur J Immunol 1995; 25:232-7.
26. + donors by cysteine protease inhibitors. J Immunol 1994; 153:862-72.
27. van Noesel CJ, Gruters RA, Terpstra FG, Schellekens PT, van Lier RA, Miedema F. Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men. J Clin Invest 1990; 86:293-9.
28. + individuals. Clin Exp Immunol 1990; 82:559-66.
29. Clerici M, Stocks NI, Zajac RA et al. Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals. Nature 1989; 339:383-5.
30. Imberti L, Sottini A, Bettinardi A, Puoti M, Primi D. Selective depletion in HIV infection of T cells that bear specific T cell receptor V beta sequences. Science 1991; 254:860-2.
31. Dalgleish AG, Wilson S, Compels M, Ludlam C, Gazzard B, Coates AM, Habeshaw . T-cell receptor variable gene products and early HIV-1 infection [published erratum appears in Lancet 1992; 339:942]. Lancet 1992; 339:824-8.
32. Posnett DN, Kabak S, Hodtsev AS, Goldberg EA, Asch A. T-cell antigen receptor V beta subsets are not preferentially deleted in AIDS. Aids 1993; 7:625-31.
33. + T cells of human immunodeficiency virus-infected infants. Eur J Immunol 1993; 23:2041-4.
34. + T cells. Aids 1993; 7:633-8.
35. + T cells of the virus-positive twins. Proc Natl Acad Sci USA 1994; 91:1529-33.
36. Meyaard L, Schuitemaker H, Miedema F. T-cell dysfunction in HIV infection: anergy due to defective antigen-presenting cell function? Immunol Today 1993; 14:161-4.
37. Manca F, Habeshaw JA, Dalgleish AG. HIV envelope glycoprotein, antigen specific T-cell responses, and soluble CD4. Lancet 1990; 335:811-5.
38. Manca F, Walker L, Newell A, Celada F, Habeshaw JA, Dalgleish AG. Inhibitory activity of HIV envelope gp120 dominates over its antigenicity for human T cells. Clin Exp Immunol 1992; 88:17-22.
39. Kovacs JA, Baseler M, Dewar RJ et al. Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study. N Engl J Med 1995; 332:567-75.